LEADER 02226nam  2200529z- 450 
001 9910557475303321
005 20231214133230.0
035   $a(CKB)5400000000043045
035   $a(oapen)https://directory.doabooks.org/handle/20.500.12854/73022
035   $a(EXLCZ)995400000000043045
100   $a20202111d2019      |y             0
101 0 $aeng
135   $aurmn|---annan
181   $ctxt$2rdacontent
182   $cc$2rdamedia
183   $acr$2rdacarrier
200 10$aIL-1 Inhibition
210   $cFrontiers Media SA$d2019
215   $a1 electronic resource (217 p.)
311   $a2-88945-857-1 
330   $aThis eBook is a collection of articles from a Frontiers Research Topic. Frontiers Research Topics are very popular trademarks of the Frontiers Journals Series: they are collections of at least ten articles, all centered on a particular subject. With their unique mix of varied contributions from Original Research to Review Articles, Frontiers Research Topics unify the most influential researchers, the latest key findings and historical advances in a hot research area! Find out more on how to host your own Frontiers Research Topic or contribute to one as an author by contacting the Frontiers Editorial Office: frontiersin.org/about/contact
606   $aScience: general issues$2bicssc
606   $aPharmacology$2bicssc
610   $aInterleukin-1
610   $aInterleukin-1 receptor antagonist
610   $aanti-interleukin-1 monoclonal antibody
610   $aInflammasomes
610   $aChronic inflammatory diseases
610   $aAutoinflammatory diseases
610   $aArthritis
610   $aOsteoathritis
610   $aSkin Diseases
610   $acrystal-induced inflammation
615  7$aScience: general issues
615  7$aPharmacology
700   $aOliviero$b Francesca$4edt$0280064
702   $aSfriso$b Paolo$4edt
702   $aPunzi$b Leonardo$4edt
702   $aDayer$b Jean-Michel$4edt
702   $aOliviero$b Francesca$4oth
702   $aSfriso$b Paolo$4oth
702   $aPunzi$b Leonardo$4oth
702   $aDayer$b Jean-Michel$4oth
906   $aBOOK
912   $a9910557475303321
996   $aIL-1 Inhibition$93038270
997   $aUNINA